Concepts (84)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Patient Handoff | 1 | 2018 | 39 | 0.630 |
Why?
|
| Hospitalists | 1 | 2018 | 57 | 0.600 |
Why?
|
| Emergency Service, Hospital | 4 | 2019 | 1148 | 0.580 |
Why?
|
| Cancer Care Facilities | 2 | 2018 | 884 | 0.560 |
Why?
|
| Hospitalization | 2 | 2018 | 2083 | 0.410 |
Why?
|
| Organizational Case Studies | 1 | 2018 | 42 | 0.160 |
Why?
|
| Computed Tomography Angiography | 1 | 2019 | 234 | 0.150 |
Why?
|
| Patient Admission | 1 | 2018 | 220 | 0.140 |
Why?
|
| Continuity of Patient Care | 1 | 2018 | 225 | 0.140 |
Why?
|
| Pulmonary Embolism | 1 | 2019 | 329 | 0.130 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2014 | 21 | 0.130 |
Why?
|
| Technetium | 1 | 1994 | 77 | 0.120 |
Why?
|
| Herpesvirus 8, Human | 1 | 2014 | 102 | 0.120 |
Why?
|
| Soft Tissue Injuries | 1 | 1994 | 51 | 0.120 |
Why?
|
| Emergency Medical Services | 1 | 2018 | 429 | 0.120 |
Why?
|
| Cancer Pain | 1 | 2018 | 312 | 0.110 |
Why?
|
| Muscular Diseases | 1 | 1994 | 161 | 0.110 |
Why?
|
| Erythrocytes | 1 | 1994 | 339 | 0.110 |
Why?
|
| Hematoma | 1 | 1994 | 160 | 0.110 |
Why?
|
| Sarcoma, Kaposi | 1 | 2014 | 187 | 0.110 |
Why?
|
| Inpatients | 1 | 2018 | 678 | 0.110 |
Why?
|
| Intensive Care Units | 1 | 2016 | 717 | 0.100 |
Why?
|
| Wounds and Injuries | 1 | 2014 | 399 | 0.100 |
Why?
|
| Hospital Mortality | 1 | 2016 | 1274 | 0.090 |
Why?
|
| Hemorrhage | 1 | 1994 | 712 | 0.090 |
Why?
|
| Sepsis | 1 | 2014 | 652 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 2403 | 0.080 |
Why?
|
| Depression | 1 | 2018 | 1715 | 0.080 |
Why?
|
| Neoplasms | 3 | 2019 | 15193 | 0.080 |
Why?
|
| Iodobenzenes | 2 | 1997 | 3 | 0.070 |
Why?
|
| Iodine Radioisotopes | 2 | 1997 | 371 | 0.060 |
Why?
|
| Middle Aged | 7 | 2019 | 86204 | 0.050 |
Why?
|
| Aged | 5 | 2019 | 70117 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2014 | 2947 | 0.050 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2019 | 68 | 0.040 |
Why?
|
| Unnecessary Procedures | 1 | 2019 | 104 | 0.040 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 1997 | 23 | 0.040 |
Why?
|
| Radionuclide Imaging | 2 | 1997 | 660 | 0.040 |
Why?
|
| Lymphatic Diseases | 1 | 1997 | 128 | 0.030 |
Why?
|
| Sarcoidosis | 1 | 1997 | 112 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2018 | 9180 | 0.030 |
Why?
|
| APACHE | 1 | 2014 | 93 | 0.030 |
Why?
|
| Paraganglioma | 1 | 1997 | 170 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2019 | 636 | 0.030 |
Why?
|
| Carotid Body Tumor | 1 | 1994 | 18 | 0.030 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 1994 | 31 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2014 | 193 | 0.030 |
Why?
|
| Salivary Glands | 1 | 1994 | 130 | 0.030 |
Why?
|
| Humans | 9 | 2019 | 261506 | 0.030 |
Why?
|
| Arm | 1 | 1994 | 147 | 0.030 |
Why?
|
| Thigh | 1 | 1994 | 172 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2014 | 519 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2014 | 709 | 0.030 |
Why?
|
| Male | 7 | 2019 | 123000 | 0.020 |
Why?
|
| Prevalence | 1 | 2018 | 3260 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2014 | 1038 | 0.020 |
Why?
|
| Female | 6 | 2019 | 141928 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2018 | 1371 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 6207 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2019 | 6869 | 0.020 |
Why?
|
| 3-Iodobenzylguanidine | 2 | 1997 | 31 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 29902 | 0.020 |
Why?
|
| Survival Rate | 1 | 2018 | 12221 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 6100 | 0.020 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 1997 | 305 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 4053 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 5159 | 0.010 |
Why?
|
| United States | 1 | 2019 | 15433 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 10331 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 1997 | 5767 | 0.010 |
Why?
|
| Adolescent | 2 | 2016 | 31252 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 21445 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 32848 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 37905 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 11965 | 0.010 |
Why?
|
| Hypercalcemia | 1 | 1997 | 137 | 0.010 |
Why?
|
| Renal Insufficiency | 1 | 1997 | 321 | 0.010 |
Why?
|
| Bone and Bones | 1 | 1997 | 619 | 0.010 |
Why?
|
| Adult | 2 | 2016 | 77950 | 0.010 |
Why?
|
| Prostate | 1 | 1997 | 1088 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1997 | 1863 | 0.010 |
Why?
|
| Biopsy | 1 | 1997 | 3443 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 1997 | 4844 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1994 | 10035 | 0.000 |
Why?
|